Skip to main content
Download PDF

Longitudinal trajectory of acidosis and mortality in acute kidney injury requiring continuous renal replacement therapy

BMC Nephrology volume 23, Article number: 411 (2022) Cite this article

Abstract

Background

Acidosis frequently occurs in severe acute kidney injury (AKI), and continuous renal replacement therapy (CRRT) can control this pathologic condition. Nevertheless, acidosis may be aggravated; thus, monitoring is essential after starting CRRT. Herein, we addressed the longitudinal trajectory of acidosis on CRRT and its relationship with worse outcomes.

Methods

The latent growth mixture model was applied to classify the trajectories of pH during the first 24 hours and those of C-reactive protein (CRP) after 24 hours on CRRT due to AKI (n = 1815). Cox proportional hazard models were used to calculate hazard ratios of all-cause mortality after adjusting multiple variables or matching their propensity scores.

Results

The patients could be classified into 5 clusters, including the normally maintained groups (1st cluster, pH = 7.4; and 2nd cluster, pH = 7.3), recovering group (3rd cluster with pH values from 7.2 to 7.3), aggravating group (4th cluster with pH values from 7.3 to 7.2), and ill-being group (5th cluster, pH < 7.2). The pH clusters had different trends of C-reactive protein (CRP) after 24 hours; the 1st and 2nd pH clusters had lower levels, but the 3rd to 5th pH clusters had an increasing trend of CRP. The 1st pH cluster had the best survival rates, and the 3rd to 5th pH clusters had the worst survival rates. This survival difference was significant despite adjusting for other variables or matching propensity scores.

Conclusions

Initial trajectories of acidosis determine subsequent worse outcomes, such as mortality and inflammation, in patients undergoing CRRT due to AKI.

Peer Review reports

Introduction

Acute kidney injury (AKI) is a critical factor in increasing the mortality of critically ill patients admitted to the intensive care unit (ICU) [1,2,3,4,5]. Continuous renal replacement therapy (CRRT) is a rescue measure for patients with both unstable vital signs and severe AKI. The number of AKI cases requiring CRRT has increased to more than 150,000 in the United States over the past few decades [6]. Despite advances in CRRT technology, the patient outcomes of CRRT due to AKI are still worse [4, 5, 7,8,9,10]. Although guidelines exist for CRRT implementation [11,12,13], CRRT-related complications can occur, and initiating CRRT does not always guarantee a survival advantage, which indicates the importance of an individualized approach [14,15,16,17].

Metabolic acidosis is an important feature in severe AKI [7, 18]. This pathologic condition is attributable to decreased excretion of nonvolatile acids via urination and decreased renal synthesis of bicarbonates [19]. CRRT can successfully control metabolic acidosis, and exogenous bicarbonates may be added during CRRT. Nevertheless, incomplete correction frequently occurs, perhaps because of less correction by CRRT or high production of acids by patient aggravation. Previous studies have investigated the correlation between pH and mortality in patients receiving CRRT [7, 18], and initial pH on CRRT was related to subsequent high mortality.

To date, no studies have considered the acidosis trend and its relationship with outcomes after starting CRRT. Herein, we aimed to address this issue by clustering the first 24-hour trajectories of pH on CRRT, and identified that certain trajectory groups had high mortality outcomes despite adjusting multiple variables or matching propensity scores. Furthermore, the pH trends determined the subsequent trend of systemic inflammation evaluated with high sensitivity C-reactive protein (CRP) levels, which might contribute to mortality differences.

Methods

Patients and data collection

A total of 2397 patients undergoing CRRT due to AKI were retrospectively reviewed at Seoul National University Hospital from June 2010 to December 2020. Patients who were aged < 18 years (n = 24) and who had end-stage kidney disease at the time of initiating CRRT (n = 91) were excluded. Patients who underwent arterial blood gas analysis less than 5 times in the first 24 hours after the initiation of CRRT (n = 467) were also excluded. Accordingly, 1815 patients were included in the analyses (Fig. 1). The study design was approved by the institutional review board of Seoul National University Hospital (No. H-2110-085-1262) and compiled with the Declaration of Helsinki. Informed consent was waived under approval.

Fig. 1
figure 1

Flow diagram for study subjects. ABGA, artery blood gas analysis

Full size image

Baseline data were collected, such as age, sex, weight, cause of AKI (e.g., septic and nonseptic), ICU division, use of inotropes, application of mechanical ventilation, type of central catheter, setting of CRRT (e.g., blood flow rate, target dose, and ultrafiltration), use of bicarbonate ampoules, and anuria status. The severity of illness was evaluated using the Charlson comorbidity index (CCI) [20], sequential organ failure assessment (SOFA) [21], and acute physiology assessment and chronic health evaluation (APACHE) II [22]. The primary outcome was all-cause mortality after starting CRRT. The high-sensitivity CRP levels were measured after 24 hours until 72 hours to determine the correlation with the first 24-hour pH trends.

Statistical analysis

Baseline characteristics are described as proportions and means ± standard deviations when categorical and continuous variables were normally distributed and as medians with interquartile ranges when they were not normally distributed. The normality of the distribution was analyzed using the Kolmogorov–Smirnov test. A chi-square test or Fisher’s exact test was used to compare categorical variables. Student’s t test or the Mann–Whitney U test was used for continuous variables with or without a normal distribution, respectively. ANOVA with post hoc analysis was used to evaluate the difference in baseline characteristics. The latent growth mixture model was applied to classify the trajectory of change in pH and CRP. To reflect the goodness of fit of the linear-linear latent growth mixture model, the Akaike information criterion, Bayesian information criterion, and sample-adjusted Bayesian information criterion were used. Cox proportional hazard models with and without stepwise adjustment of multiple variables were used to calculate the hazard ratio (HR) of mortality outcomes. We tested the proportional hazard assumption using the Schoenfeld test. Kaplan–Meier survival curves were drawn, and differences in the curves were determined using a log-rank test. Because many baseline parameters differed between groups, propensity score-based matching with inverse probability treatment weighting was additionally performed. All baseline variables were used to calculate propensity scores. A two-tailed P value less than 0.05 was considered statistically significant. All statistical analyses were performed using R software (version 4.1.2; R core team, Vienna, Austria).

Results

Baseline characteristics

The baseline characteristics are presented in Table 1. The mean age was 64 ± 15 years, and 62.8% of the patients were male. The proportion of septic AKI was 47.0, and 51.7% of the patients were hospitalized in the medical ICU. Half of the patients used inotropes and approximately 80% of patients were supported by mechanical ventilations. Half of the patients used femoral catheters as vascular access. Their SOFA and APACHE II scores were 11.9 ± 3.7 and 26.2 ± 7.8, respectively. In total, pCO2 was 35.6 ± 12.5 mmHg. Partial pressure of carbon dioxide (pCO2) was significantly higher in the 5th cluster compared to the 1st cluster (Table S2), indicating that respiratory acidosis was superimposed or respiratory compensation was not performed in the 5th cluster. Anion gap and serum lactate level were 17.7 ± 7.9 mmol/l and 6.4 ± 5.1 mmol/l, respectively. Serum anion gap and lactate were highest in the 5th cluster among clusters. However, in contrary to pCO2, serum anion gap and lactate showed abnormal levels even in the 1st cluster, suggesting that nonvolatile acids, such as lactate and phosphate, accumulated in all clusters (Table S2).

Table 1 Baseline characteristics of the patients
Full size table

Clustering of acidosis trajectories

Patients were classified into 5 clusters based on the distinctive trends of pH (Fig. 2). The 1st cluster, accounting for 31.7% of patients, showed consistently normal pH levels on CRRT. The 2nd cluster, accounting for 41.2% of patients, had suboptimal pH trajectory with initial pH 7.3, and gradually approached 7.4. The 3rd cluster, accounting for 10.2% of patients, had recovering acidosis from pH 7.2 to 7.3. The 4th cluster (10.4% of patients) had an aggravating tendency of acidosis from pH 7.3 to 7.2 in spite of performing CRRT. The 5th cluster (6.5% of patients) also had uncontrolled pH trajectory less than 7.2 despite implementation of CRRT.

Fig. 2
figure 2

Clustering of pH trajectories during the first 24 hours after starting continuous renal replacement therapy. 1st cluster, consistently normal pH levels on CRRT; 2nd cluster, suboptimal pH trajectory with initial pH 7.3, and gradually approached 7.4; 3rd cluster, recovering acidosis from pH 7.2 to 7.3; 4th cluster, aggravating tendency of acidosis from pH 7.3 to 7.2; 5th cluster, uncorrected pH trajectory less than 7.2

Full size image

The variables of age, sex, ICU division, inotrope use, blood flow rate, target dose, and CCI score were not different among the 5 clusters (Table 1). Septic AKI was most common in the 3rd cluster, explaining 58.2% of the total number. The SOFA and APACHE II scores tended to increase in the groups with low pH values, such as the 4th and 5th clusters. Mechanical ventilation was applied in 72.2% of the 5th cluster.

Association between acidosis trajectory and survival

During a median follow-up period of 10 days (interquartile range, 3–28 days), 1193 patients (65.7%) died. The mortality incidence was 26.7 deaths per 1000 patient-days. The all-cause mortality rates were 44.3, 55.7, 74.2, 78.2 and 82.2% from the 1st cluster to the 5th cluster, respectively (P < 0.001). Fig. 3 shows Kaplan–Meier survival curves of 5 clusters, and their curves were separated (P < 0.001). The mortality risk increased from the 1st cluster to the 5th cluster, irrespective of adjusting for multiple variables (Table 2). Because several baselines differed between the clusters, we matched propensity scores with two methods. Despite matching propensity scores, the mortality rates were different, similar to the above results (Table 3).

Fig. 3
figure 3

Kaplan–Meier survival curves of pH clusters for all-cause mortality. 1st cluster, consistently normal pH levels on CRRT; 2nd cluster, suboptimal pH trajectory with initial pH 7.3, and gradually approached 7.4; 3rd cluster, recovering acidosis from pH 7.2 to 7.3; 4th cluster, aggravating tendency of acidosis from pH 7.3 to 7.2; 5th cluster, uncorrected pH trajectory less than 7.2

Full size image
Table 2 Risk of mortality according to the acidosis trajectories
Full size table
Table 3 Comparison of mortality after matching propensity scores
Full size table

Association between acidosis and inflammation trajectories

To evaluate the subsequent inflammatory status, clustering was performed using the CRP values between 1 and 3 days on CRRT. A total of 3 clusters were identified by distinctive trends of CRP (Fig. 4). The 1st cluster had a stationary trend of CRP, and the 2nd and 3rd clusters had an increasing trend of CRP. The Kaplan–Meier curves showed the best survival rate in the 1st cluster. In contrast, survival rate was worst in 3rd cluster (Fig. 5). As the pH trajectory approached the normal value of 7.4, the proportion of patients with a low CRP trajectory increased (Fig. 6). The results suggest that the association between acidosis trajectories and mortality was partly attributable to subsequent inflammatory status.

Fig. 4
figure 4

Clustering of trajectories in high sensitivity C-reactive protein between 24 and 72 hours after starting continuous renal replacement therapy. 1st cluster, stationary trend of CRP less than 10 mg/dL; 2nd cluster, increasing trend of CRP between 15 and 20 mg/dL; 3rd cluster, increasing trend of CRP between 30 and 50 mg/dL

Full size image
Fig. 5
figure 5

Kaplan–Meier survival curves of high-sensitivity C-reactive protein clusters for all-cause mortality. 1st cluster, stationary trend of CRP less than 10 mg/dL; 2nd cluster, increasing trend of CRP between 15 and 20 mg/dL; 3rd cluster, increasing trend of CRP between 30 and 50 mg/dL

Full size image
Fig. 6
figure 6

Distribution of high-sensitivity C-reactive protein (CRP) clusters according to pH clusters. 1st cluster, stationary trend of CRP less than 10 mg/dL; 2nd cluster, increasing trend of CRP between 15 and 20 mg/dL; 3rd cluster, increasing trend of CRP between 30 and 50 mg/dL

Full size image

Discussion

Since AKI patients who require CRRT are in critical condition, clinicians need to consider the patient status, including vital signs, biochemical results, imaging tests, and medical history. Among these, acidosis is one that reflects hemodynamics, respiration, and tissue oxygenation at once [23, 24]. Herein, acidosis trajectories were associated with subsequent mortality and inflammatory trends after starting CRRT. The relationship between acidosis trajectories and outcomes was independent of other variables; thus, monitoring both initial and subsequent trends of acidosis is important in this patient subset.

The detrimental effect of acidosis on patient outcome has been documented, particularly in chronic kidney disease [25,26,27]. There is a consensus that metabolic acidosis leads to insulin resistance, breakdown in skeletal muscle mass, and cardiovascular complications in addition to progression of kidney disease [28,29,30]. Observational studies have shown that metabolic acidosis is associated with risks of doubling of serum creatinine and all-cause mortality compared to the counterpart normal status [25, 29, 31, 32]. Small sample-sized clinical trials on alkali supplementation and dietary intervention have demonstrated the beneficial effect of correcting metabolic acidosis on preserving kidney function in patients with chronic kidney disease [33,34,35].

Similar to chronic kidney disease, metabolic acidosis may be associated with poorer outcomes in AKI patients [36,37,38,39]. Acidosis would be both the cause and result of AKI [40]. Despite the complex relationship between acidosis and AKI, a linear relationship was observed between baseline pH and outcome in most studies [7, 18]. Here, pH trajectories after starting CRRT were diverse, and some cases could not be recovered from acidosis despite the same protocol on CRRT. Accordingly, the relationship between acidosis trajectories and mortality outcomes was prominent, which indicates that the acidosis trend, in addition to initial acid-base status, is also important for determining the patient outcomes.

The process of acidosis begins with the formation of free radicals, which leads to oxidative stress and results in endothelial dysfunction; finally, cytokines are released that make it difficult to maintain an appropriate blood pressure level [41,42,43,44]. Furthermore, acidosis causes malnutrition, which is primarily related to poor survival in patients with septic shock [45,46,47]. This pathophysiology of metabolic acidosis in AKI is similar to that of CKD, where persistent renal acidosis leads to cardiovascular complications, bone mineral disease, and CKD progression [25,26,27, 29, 30, 48, 49].

The present study has strengths, such as no missing values and concrete statistical analyses. Nonetheless, there are certain limitations to be discussed. First, because the study design was retrospective in nature, the results could not determine causality between acidosis trajectories and outcomes. Selection bias and residual confounding factors might exist, although we used matching methods to overcome them. Second, other pH-related biochemical parameters, such as pCO2, anion gap, and lactic acid, were not traced, making it difficult to interpret the independent relationship with outcomes. Nevertheless, we collected information such as baseline pCO2, anion gap, and lactate to differentiate the early causes of acidosis in each pH cluster. Finally, time-varying ICU cares, including shifts in catheter site, changes in CRRT settings, and inotropic dosage were not considered in the analysis.

In conclusion, acidosis trajectories determine subsequent worse outcomes, such as high mortality and systemic inflammatory response in patients starting CRRT due to AKI. Accordingly, precise monitoring of acidosis on CRRT may be helpful to predict patient outcomes. However, randomized clinical trial is needed to determine whether pH correction during CRRT improves the survival rate in patients with specific pH groups and to overcome the limitation of retrospective nature. Future trials will address other clinical outcomes, such as renal recovery and ventilator weaning. Hopefully, the present results will be a conceptual rationale for clinical trials with acidosis correction.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Abbreviations

AKI:

Acute kidney injury

ICU:

Intensive care unit

CRRT:

continuous renal replacement therapy

CRP:

C-reactive protein

CCI:

Charlson comorbidity index

SOFA:

sequential organ failure assessment

APACHE:

acute physiology assessment and chronic health evaluation

HR:

hazard ratio

References

  1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–70.

    Article  Google Scholar 

  2. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813–8.

    Article  CAS  Google Scholar 

  3. Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL, Investigators A. Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med. 2017;376(1):11–20.

    Article  Google Scholar 

  4. Chang JW, Jeng MJ, Yang LY, Chen TJ, Chiang SC, Soong WJ, et al. The epidemiology and prognostic factors of mortality in critically ill children with acute kidney injury in Taiwan. Kidney Int. 2015;87(3):632–9.

    Article  Google Scholar 

  5. Harris DG, McCrone MP, Koo G, Weltz AS, Chiu WC, Scalea TM, et al. Epidemiology and outcomes of acute kidney injury in critically ill surgical patients. J Crit Care. 2015;30(1):102–6.

    Article  Google Scholar 

  6. Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu CY. Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol. 2013;24(1):37–42.

    Article  Google Scholar 

  7. Prasad B, Urbanski M, Ferguson TW, Karreman E, Tangri N. Early mortality on continuous renal replacement therapy (CRRT): the prairie CRRT study. Can J Kidney Health Dis. 2016;3:36.

    Article  Google Scholar 

  8. Allegretti AS, Steele DJ, David-Kasdan JA, Bajwa E, Niles JL, Bhan I. Continuous renal replacement therapy outcomes in acute kidney injury and end-stage renal disease: a cohort study. Crit Care. 2013;17(3):R109.

    Article  Google Scholar 

  9. Santiago MJ, Lopez-Herce J, Urbano J, Solana MJ, del Castillo J, Ballestero Y, et al. Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy. Intensive Care Med. 2010;36(5):843–9.

    Article  Google Scholar 

  10. Keleshian V, Kashani KB, Kompotiatis P, Barsness GW, Jentzer JC. Short, and long-term mortality among cardiac intensive care unit patients started on continuous renal replacement therapy. J Crit Care. 2020;55:64–72.

    Article  Google Scholar 

  11. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–84.

    Article  Google Scholar 

  12. Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, et al. A European renal best practice (ERBP) position statement on the kidney disease improving global outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27(12):4263–72.

    Article  Google Scholar 

  13. Jorres A, John S, Lewington A, ter Wee PM, Vanholder R, Van Biesen W, et al. Ad-hoc working group of E: a European renal best practice (ERBP) position statement on the kidney disease improving global outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 2: renal replacement therapy. Nephrol Dial Transplant. 2013;28(12):2940–5.

    Article  Google Scholar 

  14. Bouchard J, Cutter G, Mehta R. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383(18):1796.

    Article  Google Scholar 

  15. Barbar SD, Clere-Jehl R, Bourredjem A, Hernu R, Montini F, Bruyere R, et al. Timing of renal-replacement therapy in patients with acute kidney injury and Sepsis. N Engl J Med. 2018;379(15):1431–42.

    Article  CAS  Google Scholar 

  16. Clark E, Wald R, Walsh M, Bagshaw SM. Canadian acute kidney injury I: timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada. Nephrol Dial Transplant. 2012;27(7):2761–7.

    Article  Google Scholar 

  17. Agapito Fonseca J, Gameiro J, Marques F, Lopes JA. Timing of initiation of renal replacement therapy in Sepsis-associated acute kidney injury. J Clin Med. 2020;9(5).

  18. Kee YK, Kim D, Kim SJ, Kang DH, Choi KB, Oh HJ, et al. Factors associated with early mortality in critically ill patients following the initiation of continuous renal replacement therapy. J Clin Med. 2018;7(10).

  19. Soleimani M, Rastegar A. Pathophysiology of renal tubular acidosis: Core curriculum 2016. Am J Kidney Dis. 2016;68(3):488–98.

    Article  Google Scholar 

  20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

    Article  CAS  Google Scholar 

  21. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on Sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10.

    Article  CAS  Google Scholar 

  22. Rowan KM, Kerr JH, Major E, McPherson K, Short A, Vessey MP. Intensive Care Society's acute physiology and chronic health evaluation (APACHE II) study in Britain and Ireland: a prospective, multicenter, cohort study comparing two methods for predicting outcome for adult intensive care patients. Crit Care Med. 1994;22(9):1392–401.

    Article  CAS  Google Scholar 

  23. Kraut JA, Madias NE. Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol. 2012;8(10):589–601.

    Article  CAS  Google Scholar 

  24. Sato Y, Weil MH, Tang W. Tissue hypercarbic acidosis as a marker of acute circulatory failure (shock). Chest. 1998;114(1):263–74.

    Article  CAS  Google Scholar 

  25. Shah SN, Abramowitz M, Hostetter TH, Melamed ML. Serum bicarbonate levels and the progression of kidney disease: a cohort study. Am J Kidney Dis. 2009;54(2):270–7.

    Article  CAS  Google Scholar 

  26. Raphael KL, Wei G, Baird BC, Greene T, Beddhu S. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int. 2011;79(3):356–62.

    Article  CAS  Google Scholar 

  27. Wesson DE, Simoni J. Increased tissue acid mediates a progressive decline in the glomerular filtration rate of animals with reduced nephron mass. Kidney Int. 2009;75(9):929–35.

    Article  CAS  Google Scholar 

  28. Garibotto G, Sofia A, Russo R, Paoletti E, Bonanni A, Parodi EL, et al. Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis. Kidney Int. 2015;88(6):1419–26.

    Article  CAS  Google Scholar 

  29. Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, et al. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2013;62(4):670–8.

    Article  CAS  Google Scholar 

  30. Abramowitz MK. Metabolic acidosis and cardiovascular disease risk in CKD. Clin J Am Soc Nephrol. 2018;13(10):1451–2.

    Article  Google Scholar 

  31. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. Nephrol Dial Transplant. 2009;24(4):1232–7.

    Article  CAS  Google Scholar 

  32. Raikou VDMP. Metabolic acidosis status and mortality in patients on the end stage of renal disease. J Transl Int Med. 2016;4(4):170–7.

    Article  Google Scholar 

  33. Goraya N, Simoni J, Jo CH, Wesson DE. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int. 2014;86(5):1031–8.

    Article  CAS  Google Scholar 

  34. Raphael KL, Greene T, Wei G, Bullshoe T, Tuttle K, Cheung AK, et al. Sodium bicarbonate supplementation and urinary TGF-beta1 in nonacidotic diabetic kidney disease: a randomized, controlled trial. Clin J Am Soc Nephrol. 2020;15(2):200–8.

    Article  CAS  Google Scholar 

  35. Jeong J, Kwon SK, Kim HY. Effect of bicarbonate supplementation on renal function and nutritional indices in predialysis advanced chronic kidney disease. Electrolyte Blood Press. 2014;12(2):80–7.

    Article  CAS  Google Scholar 

  36. Gunnerson KJ, Saul M, He S, Kellum JA. Lactate versus non-lactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit Care. 2006;10(1):R22.

    Article  Google Scholar 

  37. Liu X, Feng Y, Zhu X, Shi Y, Lin M, Song X, et al. Serum anion gap at admission predicts all-cause mortality in critically ill patients with cerebral infarction: evidence from the MIMIC-III database. Biomarkers. 2020;25(8):725–32.

    Article  CAS  Google Scholar 

  38. Chen Q, Chen Q, Li L, Lin X, Chang SI, Li Y, et al. Serum anion gap on admission predicts intensive care unit mortality in patients with aortic aneurysm. Exp Ther Med. 2018;16(3):1766–77.

    Google Scholar 

  39. Zhao Y, Feng SY, Li Y. Serum anion gap at admission as a predictor of the survival of patients with paraquat poisoning: a retrospective analysis. Medicine (Baltimore). 2020;99(31):e21351.

    Article  CAS  Google Scholar 

  40. Hu J, Wang Y, Geng X, Chen R, Xu X, Zhang X, et al. Metabolic acidosis as a risk factor for the development of acute kidney injury and hospital mortality. Exp Ther Med. 2017;13(5):2362–74.

    Article  CAS  Google Scholar 

  41. Himmelfarb J, McMonagle E, Freedman S, Klenzak J, McMenamin E, Le P, et al. Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol. 2004;15(9):2449–56.

    Article  CAS  Google Scholar 

  42. Alonso de Vega JM. Diaz J, serrano E, Carbonell LF: oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med. 2002;30(8):1782–6.

    Article  Google Scholar 

  43. Goodyear-Bruch C, Pierce JD. Oxidative stress in critically ill patients. Am J Crit Care. 2002;11(6):543–51.

    Article  Google Scholar 

  44. Crimi E, Taccone FS, Infante T, Scolletta S, Crudele V, Napoli C. Effects of intracellular acidosis on endothelial function: an overview. J Crit Care. 2012;27(2):108–18.

    Article  CAS  Google Scholar 

  45. Agarwal E, Ferguson M, Banks M, Batterham M, Bauer J, Capra S, et al. Malnutrition and poor food intake are associated with prolonged hospital stay, frequent readmissions, and greater in-hospital mortality: results from the nutrition care day survey 2010. Clin Nutr. 2013;32(5):737–45.

    Article  Google Scholar 

  46. Seo MH, Choa M, You JS, Lee HS, Hong JH, Park YS, et al. Hypoalbuminemia, Low Base excess values, and tachypnea predict 28-day mortality in severe Sepsis and septic shock patients in the emergency department. Yonsei Med J. 2016;57(6):1361–9.

    Article  CAS  Google Scholar 

  47. Kalantar-Zadeh K, Mehrotra R, Fouque D, Kopple JD. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial. 2004;17(6):455–65.

    Article  Google Scholar 

  48. Bushinsky DA, Krieger NS. Effects of acid on bone. Kidney Int. 2022;101(6):1160–70.

    Article  CAS  Google Scholar 

  49. Domrongkitchaiporn S, Pongskul C, Sirikulchayanonta V, Stitchantrakul W, Leeprasert V, Ongphiphadhanakul B, et al. Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosis. Kidney Int. 2002;62(6):2160–6.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Seoul National University College of Medicine 103 Daehakro, Jongno-gu, Seoul, 03080, South Korea

    Jinwoo Lee, Seong Geun Kim, Donghwan Yun, Min Woo Kang, Yong Chul Kim, Dong Ki Kim, Kook-Hwan Oh, Kwon Wook Joo, Yon Su Kim & Seung Seok Han

  2. Department of Internal Medicine, Inje University College of Medicine, Busan, South Korea

    Ho Seok Koo

Authors
  1. Jinwoo Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seong Geun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Donghwan Yun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Min Woo Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yong Chul Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dong Ki Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kook-Hwan Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kwon Wook Joo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yon Su Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ho Seok Koo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Seung Seok Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JL and SSH designed the study. JL, SGK, DY, and MWK analyzed the data. YCK, DKK, KHO, KWJ, YSK, and SSH collected the data. DKK and HSK critically read the manuscript. JL and SSH wrote the manuscript. All authors approved the final manuscript.

Corresponding author

Correspondence to Seung Seok Han.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics in Research Committee of the Seoul National University Hospital and informed consents were waived by the same committee (number: H-2110-085-1262. All methods were carried out in accordance with relevant guidelines and regulations’ or the Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

All the authors declared no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Table S1. Baseline patient characteristics after extreme gradient boosting model with inverse probability treatment weighting-based propensity scores matching.

Additional file 2:

Table S2. Baseline serum pH determinants according to the pH clusters.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, J., Kim, S.G., Yun, D. et al. Longitudinal trajectory of acidosis and mortality in acute kidney injury requiring continuous renal replacement therapy. BMC Nephrol 23, 411 (2022). https://doi.org/10.1186/s12882-022-03047-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12882-022-03047-4

Keywords

BMC Nephrology

ISSN: 1471-2369

Contact us